Skip to main content

Month: January 2026

GCC Reports Fourth Quarter and Full Year 2025 Results

CHIHUAHUA, Mexico, Jan. 27, 2026 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading supplier and producer of cement, aggregates, and concrete in the United States and Mexico, announced today its results for the fourth quarter and full year of 2025. FY 2025 HIGHLIGHTSConsolidated net sales increased 3.1% year-on-year to US$1,408.7 million U.S. sales grew 7.2% as concrete and cement volumes increased 31.5% and 2.6%, respectively U.S. concrete prices increased 10.9% Mexico concrete and cement prices increased 2.3% and 1.9%, respectively EBITDA decreased 1.7% to US$491.8 million, with a 34.9% EBITDA margin Cash and equivalents totaled US$969.5 million Net leverage (net debt/EBITDA) ratio totaled -0.71x as of December 2025 Earnings per share decreased 8.2% year-on-year, to US$0.9140 Free cash flow totaled US$349.1 million...

Continue reading

Space Asset Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

PRINCETON, NJ, Jan. 27, 2026 (GLOBE NEWSWIRE) — Space Asset Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to commence trading on January 28, 2026 on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “SAAQU.” Each unit sold in the offering consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “SAAQ” and “SAAQW,” respectively. The offering is...

Continue reading

AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering

OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, announced today changes to the previously announced key dates relating to its proposed rights offering (the “Rights Offering”). Except as expressly amended herein, the terms of the Rights Offering remain unchanged. Assuming that the Rights Offering is fully subscribed, the Company will receive gross proceeds of $12 million, less expenses related to the Rights Offering. The Subscription Rights will be non-transferable and may only be exercised during the amended subscription period of Wednesday, February 11, 2026 through 5:00 p.m. Eastern Time on...

Continue reading

Range Announces Conference Call to Discuss Fourth Quarter 2025 Financial Results

FORT WORTH, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) announced today that its fourth quarter 2025 financial results news release will be issued Tuesday, February 24 after the close of trading on the New York Stock Exchange. A conference call to review the financial results is scheduled on Wednesday, February 25 at 9:00 a.m. ET (8:00 a.m. CT). A webcast of the call may be accessed at www.rangeresources.com. The webcast will be archived for replay on the Company’s website until March 26, 2026. RANGE RESOURCES CORPORATION (NYSE: RRC) is a leading U.S. independent natural gas and NGL producer with operations focused in the Appalachian Basin. The Company is headquartered in Fort Worth, Texas. More information about Range can be found at www.rangeresources.com. SOURCE: Range Resources Corporation Range...

Continue reading

Orrstown Financial Services, Inc. Reports Fourth Quarter 2025 Results and Announces Dividend Increase

Net income of $21.5 million, or $1.11 per diluted earnings per share, for the three months ended December 31, 2025 compared to net income of $21.9 million, or $1.13 per diluted earnings per share, for the three months ended September 30, 2025; Net income of $80.9 million and diluted earnings per share of $4.18 for the year ended December 31, 2025 compared to net income of $22.1 million and diluted earnings per share of $1.48 for the year ended December 31, 2024; Adjusted net income and diluted earnings per share totaled $82.9 million(1) and $4.28(1), respectively, for the year ended December 31, 2025 compared to $56.1 million(1) and $3.76(1), respectively, for the year ended December 31, 2024 (excluding certain previously disclosed non-recurring expenses for both periods); Return on average assets was 1.55% and return on average equity...

Continue reading

K12 Demand Remains Strong

RESTON, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) — Stride, Inc. (NYSE: LRN), one of the nation’s most successful technology-based education companies, today announced its results for the second quarter of fiscal year 2026 ended December 31, 2025. Second Quarter Fiscal 2026 Highlights Compared to 2025Revenue of $631.3 million, compared with $587.2 million Income from operations of $146.9 million, compared with $125.1 million Net income of $99.5 million, compared with $96.4 million Diluted net income per share of $2.12, compared with $2.03 Adjusted operating income of $159.0 million, compared with $135.6 million (1) Adjusted EBITDA of $188.1 million, compared with $160.4 million (1) Adjusted earnings per share of $2.50, compared with $2.37 (1) Core platform issues stabilized; enhancements ongoingSecond Quarter Fiscal 2026 Summary...

Continue reading

National Bank Holdings Corporation Announces Fourth Quarter and Full Year 2025 Financial Results

DENVER, Jan. 27, 2026 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (the “Company” or “NBHC”) reported:  For the quarter(1)   For the year   2025 Adjusted (1)(2)  4Q25   3Q25   4Q24   2025     2024     QTD   YTDNet income ($000’s) $ 16,036     $ 35,285     $ 28,184     $ 109,574     $ 118,815     $ 22,748     $ 117,622  Earnings per share – diluted $ 0.42     $ 0.92     $ 0.73     $ 2.85     $ 3.08     $ 0.60     $ 3.06  Return on average assets   0.65 %     1.43 %     1.13 %     1.11 %     1.20 %     0.92 %     1.19 %Return on average tangible assets(2)   0.73 %     1.54 %     1.23 %     1.22 %     1.30 %     1.02 %     1.30 %Return on average equity   4.57 %     10.25 %     8.59 %     8.08 %     9.41 %     6.48 %     8.67 %Return on average tangible common equity(2)   6.58 %     14.21 %     12.31 %     11.36 %     13.65 %     9.10 %     12.15 %                                                      (1) Quarterly...

Continue reading

Millicom (Tigo) announces successful bid for EPM’s Stake in UNE

Millicom (Tigo) announces successful bid for EPM’s Stake in UNE Luxembourg, January 27,2026 — Millicom International Cellular S.A. (“Millicom”) today announced that it has been awarded 100% of EPM’s remaining shares in UNE EPM Telecommunicaciones S.A. (“UNE” or “Tigo Colombia”), following a winning bid in the public auction conducted by Empresas Públicas de Medellín E.S.P. (“EPM”). Millicom’s bid was COP 418,741 per share, representing a total consideration of approximately COP 2.1 trillion, (approximately USD 571 million). This acquisition consolidates Millicom’s ownership in UNE to nearly 100%, following the successful completion of the public divestment process managed by EPM in accordance with Colombian Law 226. The transaction is expected to close on January 29, 2026, in accordance with the established auction...

Continue reading

Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring

Proposed $1.0 million Convertible Debenture and concurrent $500,000 Private Placement Intended to Support Near-Term Operations Board and Management Enhancements Strengthen Governance and Capital Markets Execution Current Convertible Debenture Maturity Extended; Further Debt Optimization Planned VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel cancer therapies, today provides a comprehensive corporate update addressing near-term financing, leadership and board changes, and the restructuring of its outstanding convertible debt, each subject to applicable regulatory and TSX Venture Exchange (“Exchange”) approvals. CONVERTIBLE DEBENTURE EXTENSION AND DEBT RESTRUCTURING Rakovina...

Continue reading

World of Concrete Unites Global Construction Leaders to Shape the Future of Concrete and Masonry Construction

1,300+ exhibitors, extensive education, interactive exhibits and more supporting the commercial construction industry at World of Concrete 2026 LAS VEGAS, Jan. 27, 2026 (GLOBE NEWSWIRE) — World of Concrete, the most comprehensive event dedicated to the concrete construction and masonry industries, concluded last week at the Las Vegas Convention Center, uniting more than 47,400 registered professionals to connect on the future of construction and discover breakthrough resources for education, skill development and workforce growth. Global Innovation & Market Growth More than 1,300 exhibiting companies spanned multiple product categories including material handling, concrete producers, construction technology, precast, concrete masonry, concrete reinforcement, cement production, demolition and repair, surfaces and decorative....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.